Desirable L-asparaginases for treating cancer and current research trends
Amino acid depletion therapy is a promising approach for cancer treatment. It exploits the differences in the metabolic processes between healthy and cancerous cells. Certain microbial enzymes induce cancer cell apoptosis by removing essential amino acids. L-asparaginase is an enzyme approved by the...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-03-01
|
| Series: | Frontiers in Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2024.1269282/full |
| _version_ | 1827308991797002240 |
|---|---|
| author | Kindu Tsegaye Berhanu Andualem Tsehai Birhan Getie |
| author_facet | Kindu Tsegaye Berhanu Andualem Tsehai Birhan Getie |
| author_sort | Kindu Tsegaye |
| collection | DOAJ |
| description | Amino acid depletion therapy is a promising approach for cancer treatment. It exploits the differences in the metabolic processes between healthy and cancerous cells. Certain microbial enzymes induce cancer cell apoptosis by removing essential amino acids. L-asparaginase is an enzyme approved by the FDA for the treatment of acute lymphoblastic leukemia. The enzymes currently employed in clinics come from two different sources: Escherichia coli and Erwinia chrysanthemi. Nevertheless, the search for improved enzymes and other sources continues because of several factors, including immunogenicity, in vivo instability, and protease degradation. Before determining whether L-asparaginase is clinically useful, research should consider the Michaelis constant, turnover number, and maximal velocity. The identification of L-asparaginase from microbial sources has been the subject of various studies. The primary goals of this review are to explore the most current approaches used in the search for therapeutically useful L-asparaginases and to establish whether these investigations identified the crucial characteristics of L-asparaginases before declaring their therapeutic potential. |
| first_indexed | 2024-04-24T19:21:28Z |
| format | Article |
| id | doaj.art-04161d92ec8a443fa34dfe86e2695cf9 |
| institution | Directory Open Access Journal |
| issn | 1664-302X |
| language | English |
| last_indexed | 2024-04-24T19:21:28Z |
| publishDate | 2024-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Microbiology |
| spelling | doaj.art-04161d92ec8a443fa34dfe86e2695cf92024-03-25T17:16:08ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2024-03-011510.3389/fmicb.2024.12692821269282Desirable L-asparaginases for treating cancer and current research trendsKindu Tsegaye0Berhanu Andualem Tsehai1Birhan Getie2Department of Industrial Biotechnology, Institute of Biotechnology, University of Gondar, Gondar, EthiopiaDepartment of Biotechnology, University of Gondar, Gondar, EthiopiaDepartment of Industrial Biotechnology, Institute of Biotechnology, University of Gondar, Gondar, EthiopiaAmino acid depletion therapy is a promising approach for cancer treatment. It exploits the differences in the metabolic processes between healthy and cancerous cells. Certain microbial enzymes induce cancer cell apoptosis by removing essential amino acids. L-asparaginase is an enzyme approved by the FDA for the treatment of acute lymphoblastic leukemia. The enzymes currently employed in clinics come from two different sources: Escherichia coli and Erwinia chrysanthemi. Nevertheless, the search for improved enzymes and other sources continues because of several factors, including immunogenicity, in vivo instability, and protease degradation. Before determining whether L-asparaginase is clinically useful, research should consider the Michaelis constant, turnover number, and maximal velocity. The identification of L-asparaginase from microbial sources has been the subject of various studies. The primary goals of this review are to explore the most current approaches used in the search for therapeutically useful L-asparaginases and to establish whether these investigations identified the crucial characteristics of L-asparaginases before declaring their therapeutic potential.https://www.frontiersin.org/articles/10.3389/fmicb.2024.1269282/fullacute lympho blastic leukemiacancerkinetic propertiesL-asparaginaseMichaelis constant |
| spellingShingle | Kindu Tsegaye Berhanu Andualem Tsehai Birhan Getie Desirable L-asparaginases for treating cancer and current research trends Frontiers in Microbiology acute lympho blastic leukemia cancer kinetic properties L-asparaginase Michaelis constant |
| title | Desirable L-asparaginases for treating cancer and current research trends |
| title_full | Desirable L-asparaginases for treating cancer and current research trends |
| title_fullStr | Desirable L-asparaginases for treating cancer and current research trends |
| title_full_unstemmed | Desirable L-asparaginases for treating cancer and current research trends |
| title_short | Desirable L-asparaginases for treating cancer and current research trends |
| title_sort | desirable l asparaginases for treating cancer and current research trends |
| topic | acute lympho blastic leukemia cancer kinetic properties L-asparaginase Michaelis constant |
| url | https://www.frontiersin.org/articles/10.3389/fmicb.2024.1269282/full |
| work_keys_str_mv | AT kindutsegaye desirablelasparaginasesfortreatingcancerandcurrentresearchtrends AT berhanuandualemtsehai desirablelasparaginasesfortreatingcancerandcurrentresearchtrends AT birhangetie desirablelasparaginasesfortreatingcancerandcurrentresearchtrends |